Zamagni E, Dhanasiri S, Ghale A, Moore A, et al. Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-b Leuk Lymphoma 2021 Jun 14:1-10. doi: 10.1080/10428194.2021.1924369.
PMID: 34121589